<DOC>
	<DOCNO>NCT01825044</DOCNO>
	<brief_summary>This open label study pharmacokinetics safety ciclosporin patient severe traumatic brain injury , require intensive care unit admission monitor intracranial pressure via ventricular catheter . 20 patient screen , subsequently enrol clinical stabilisation . Thereafter , patient receive 2.5 mg/kg bolus dose infusion ciclosporin , follow either 5 mg/kg/day 10 mg/kg/day ciclosporin continuous infusion 5 days+3 day monitor intensive care unit . After additional 30 day , follow-up phone call make patient , patient 's nursing staff , check patient status serious adverse event . The two dose level investigate 10 patient , start low dose level first 10 patient . Patients sample blood cerebrospinal fluid draw pre-defined time point study pharmacokinetic assessment evaluation biomarkers . Bedside monitor microdialysis brain tissue oxygenation perform . The safety monitoring include nephrotoxicity , hepatotoxicity , monitor intracranial pressure ( ICP ) , infection monitor adverse event collection reporting .</brief_summary>
	<brief_title>Copenhagen Head Injury Ciclosporin ( CHIC ) Study</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>1 . Male female patient , age 18 75 year , inclusive . 2 . Requirement Intensive Care Unit ( ICU ) admission clinical indication External Ventricular Drainage ( EVD ) Intracranial Pressure ( ICP ) monitoring . 3 . Evidence nonpenetrating severe TBI , confirm history abnormality consistent nonpenetrating trauma computerise tomography ( CT ) scan upon admission . 4 . Clinical examination postresuscitation Glasgow Coma Scale ( GCS ) 48 , inclusive . 5 . Hemodynamically stable resuscitation ( systolic blood pressure ( SBP ) &gt; 100 mm Hg ) . 6 . Informed consent participation waive : obtain two independent physician subsequently , patient 's Legally Acceptable Representative ( LAR ) General Practitioner ( GP ) . If GP unavailable , Danish Health Medicines Authority give consent together LAR . 1 . Bilaterally fix dilate pupil . 2 . Penetrating traumatic brain injury . 3 . Spinal cord injury . 4 . Pure epidural haematoma . 5 . Currently develop , know medical history renal disorder , significant renal failure , high risk renal failure , define : 1 . Serum creatinine ≥ 1.5 x upper limit normal ( ULN ) . 2 . Preexisting chronic renal failure estimate glomerular filtration rate ( eGFR ) &lt; 60 ml/min/1.73m2 estimate simplified Modification Diet Renal Disease ( MDRD ) Study formula . 3 . Major rhabdomyolysis serum creatine kinase &gt; 5,000 IU/L . 4 . Renal injury result loss kidney ( either due direct trauma ischaemia ) . 5 . Vascular injury renal ischaemia likely cause episode acute renal failure . 6 . Any history renal replacement therapy . 6 . Known medical history hepatic disease . 7 . Prolonged and/or uncorrectable hypoxia , judge investigator ( PaO &lt; 60 mmHg ) hypotension ( SBP &lt; 90 mmHg ) upon admission . 8 . Suspected confirmed pregnancy ( positive urine sample , follow confirmational serum human chorionic gonadotropin ( HCG ) pregnancy test ) . 9 . Immunosuppression due drug ( ex . ciclosporin ) disease ( e.g . human immunodeficiency virus ( HIV ) , malignancy ) . 10 . Known medical history serious chronic viral fungal infection . 11 . Known medical history active mycobacterial infection antituberculous treatment . 12 . Known medical history allergic reaction and/or anaphylactic reaction towards ciclosporin , egg , peanut soyabean protein . 13 . Ongoing preinjury therapy drug : rosuvastatin , tacrolimus , Hypericum perforatum ( St.John´s Wort ; herbal dietary supplement ) , stiripentol , aliskiren , bosentan , diltiazem , verapamil antiepileptic . 14 . Participation clinical trial . 15 . Any significant disease disorder include abnormal laboratory test , opinion investigator , may either put patient risk participation study , may influence result study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Traumatic Brain Injury</keyword>
	<keyword>TBI</keyword>
	<keyword>ciclosporin</keyword>
	<keyword>pharmacokinetic</keyword>
	<keyword>safety</keyword>
	<keyword>microdialysis</keyword>
	<keyword>mitochondrial protection</keyword>
</DOC>